The Curos disinfecting cap is a single-use device used to protect needleless connectors of vascular access devices. Curos contains foam impregnated with 70% isopropyl alcohol, which is capable of killing micro-organisms commonly responsible for central-line-associated bloodstream infections (CLABSI).
 
Status In progress
Process MT
ID number 396

Provisional Schedule

Committee meeting: 2 22 February 2019
Resolution 25 March 2019
Expected publication 09 May 2019

Project Team

Project lead Kimberley Carter

Email enquiries

Stakeholders

External assessment group CEDAR
Manufacturers 3M
Others Boston Scientific
  Department of Health and Social Care
  Greater Manchester Health & Social Care Partnership
  Healthcare Improvement Scotland
  Johnson & Johnson Medical Ltd
  Medicines and Healthcare Products Regulatory Agency
  NHS England
Patient carer organisations Teenage Cancer Trust
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Devices for Dignity
  Radiotherapy and Care (AXrEM)
  HealthTech Alliance
  Medical Technology Group
  The British In Vitro Diagnostics Association (BIVDA)

Timeline

Key events during the development of the guidance:

Date Update
18 January 2019 - 15 February 2019 Draft guidance
14 December 2018 Committee meeting: 1
30 August 2018 Scope published
23 July 2018 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance